Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma
Cancer Science · 2024
DOI: 10.1111/cas.16025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Daichi Tamura und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Iwate Medical University School of Medicine, Yahaba, Japan. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Circulating Tumor DNA. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Iwate Prefectural Regional Innovation Grant, Japan Society for the Promotion of Science, Keiryokai Research Grant.
Abstract (Originalsprache)
Biomarkers that could detect the postoperative recurrence of upper tract urothelial carcinoma (UTUC) have not been established. In this prospective study, we aim to evaluate the utility of individualized circulating tumor DNA (ctDNA) monitoring using digital PCR (dPCR) as a tumor recurrence biomarker for UTUC in the perioperative period. Twenty‐three patients who underwent radical nephroureterectomy (RNU) were included. In each patient, whole exome sequencing by next‐generation sequencing and TERT promoter sequencing of tumor DNA were carried out. Case‐specific gene mutations were selected from sequencing analysis to examine ctDNA by dPCR analysis. We also prospectively collected plasma and urine ctDNA from each patient. The longitudinal variant allele frequencies of ctDNA during the perioperative period were plotted. Case‐specific gene mutations were detected in 22 cases (96%) from ctDNA in the preoperative samples. Frequently detected genes were TERT (39%), FGFR3 (26%), TP53 (22%), and HRAS (13%). In all cases, we obtained plasma and urine samples for 241 time points and undertook individualized ctDNA monitoring for 2 years after RNU. Ten patients with intravesical recurrence had case‐specific ctDNA detected in urine at the time of recurrence. The mean lead time of urinary ctDNA in intravesical recurrence was 60 days (range, 0–202 days). Two patients with distal metastasis had case‐specific ctDNA in plasma at the time of metastasis. In UTUC, tumor‐specific gene mutations can be monitored postoperatively as ctDNA in plasma and urine. Individualized ctDNA might be a minimally invasive biomarker for the early detection of postoperative recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Iwate Medical University School of Medicine, Yahaba, Japan.
- Division of Biomedical Research and Development, Iwate Medical University Institute for Biomedical Sciences, Yahaba, Japan.
- Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
- Department of Computational Biology and Medical Sciences, The University of Tokyo, Kashiwa, Japan.
- Department of Clinical Oncology, Iwate Medical University School of Medicine, Yahaba, Japan.
ORCID-Profile: Daichi Tamura, Ryo Takata, Hidewaki Nakagawa, Wataru Obara
Förderung
- Iwate Prefectural Regional Innovation Grant
- Japan Society for the Promotion of Science
- Keiryokai Research Grant
Zitieren
APA
Tamura, D., Abe, M., Hiraki, H., Sasaki, N., Yashima-Abo, A., Ikarashi, D., Kato, R., Kato, Y., Maekawa, S., Kanehira, M., Takata, R., Maejima, K., Sasagawa, S., Fujita, M., Suzuki, Y., Nakagawa, H., Iwaya, T., Nishizuka, S. S., & Obara, W. (2024). Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma. Cancer Science. https://doi.org/10.1111/cas.16025
Vancouver
Tamura D, Abe M, Hiraki H, Sasaki N, Yashima-Abo A, Ikarashi D, et al. Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma. Cancer Science. 2024. doi:10.1111/cas.16025
BibTeX
@article{Tamura2024,
author = {Tamura, Daichi and Abe, Masakazu and Hiraki, Hayato and Sasaki, Noriyuki and Yashima-Abo, Akiko and Ikarashi, Daiki and Kato, Renpei and Kato, Yoichiro and Maekawa, Shigekatsu and Kanehira, Mitsugu and Takata, Ryo and Maejima, Kazuhiro and Sasagawa, Shota and Fujita, Masashi and Suzuki, Yutaka and Nakagawa, Hidewaki and Iwaya, Takeshi and Nishizuka, Satoshi S and Obara, Wataru},
title = {Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma},
journal = {Cancer Science},
year = {2024},
doi = {10.1111/cas.16025}
}
EUVIMED